Physiogenix provides preclinical research services for diabetes, behavioral and cardiovascular diseases. Our services include in vivo efficacy, pharmacodynamic (PD) and pharmacokinetic (PK) studies coupled with our proprietary research models. Our team of experts deliver fast, cost-effective preclinical research services to pharmaceutical, biopharma and medical device companies.
Our team of highly trained PhD and MS scientists engage in the design and execution of your preclinical drug development program using our AALAC approved animal facilities, proprietary animal models, and in vivo surgical expertise. This results are fast delivery, cost-effective preclinical research services for pharmaceutical, biopharma and medical device companies.
|05/01/04||Seed||3M||Governor’s Small Business Technology Transfer Award||Unknown|